Merck acquires OncoEthix for up to $375 million By: MarketWatch December 18, 2014 at 08:41 AM EST Merck acquires privately-held, Swiss-based biotechnology company OncoEthix for up to $375 million, its latest push into the oncology market. Read More >> Related Stocks: Macy's Merck & Co